RECRUITINGOBSERVATIONAL
Prospective Bladder Cancer Infrastructure (ProBCI)
Prospective Bladder Cancer Infrastructure: an Infrastructure for Observational and Interventional Bladder Cancer Research (ProBCI)
About This Trial
Prospective nation-wide cohort of high-risk non-muscle-invasive, muscle-invasive and metastatic bladder cancer in the Netherlands
Who May Be Eligible (Plain English)
Who May Qualify:
- Bladder cancer
- Any stage except Ta
- 18 years or older
- Written willing to sign a consent form
Who Should NOT Join This Trial:
- No exclusion criteria
Note: participation in ProBCI does not exclude the patient from participation in other studies.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Bladder cancer
* Any stage except Ta
* 18 years or older
* Written informed consent
Exclusion Criteria:
* No exclusion criteria
Note: participation in ProBCI does not exclude the patient from participation in other studies.
Locations (20)
Jeroen Bosch Hospital
's-Hertogenbosch, Netherlands
ZGT
Almelo, Netherlands
Meander Medical Center
Amersfoort, Netherlands
Amsterdam UMC, location VUMC
Amsterdam, Netherlands
Rijnstate
Arnhem, Netherlands
Amphia Ziekenhuis
Breda, Netherlands
Albert Schweitzer Hospital
Dordrecht, Netherlands
Ziekenhuis Gelderse Vallei
Ede, Netherlands
Treant Hospital
Emmen, Netherlands
University Medical Center Groningen
Groningen, Netherlands
Spaarne Gasthuis
Hoofddorp, Netherlands
Medisch Centrum Leeuwarden
Leeuwarden, Netherlands
Alrijne Ziekenhuis
Leiderdorp, Netherlands
Maastricht University Medical Center
Maastricht, Netherlands
Canisius Wilhelmina Ziekenhuis
Nijmegen, Netherlands
Radboud univerisity Medical Center
Nijmegen, Netherlands
Erasmus Medical Center
Rotterdam, Netherlands
Zuyderland
Sittard, Netherlands
Elisabeth-TweeSteden Ziekenhuis
Tilburg, Netherlands
University Medical Center Utrecht
Utrecht, Netherlands